IAS Injecting Drug Use Research Prizes – Annual prizes
The five US$2,000 IAS Injecting Drug Use Research Prizes are awarded by the IAS HIV Co-Infections and Co-Morbidities initiative. They are incentives for researchers to address important research questions around the management of HCV infection and/or HIV/HCV co-infection in people who inject drugs, particularly through interdisciplinary research on drug dependence, harm reduction and/or drug policy. The prizes are presented to the three top-scoring abstracts in any of these areas.
Eligible candidates are presenting authors of abstracts submitted to IAS 2019, which meet the following criteria:
- The Scientific Programme Committee has accepted the abstract as an oral presentation, for a poster discussion session or for the poster exhibition.
- The research demonstrates innovation, originality, rationale and quality.
- The title or abstract body contains at least two of the following keywords: “injecting drug use”, “people who inject drugs”, “PWID”, “HCV”, “addiction”, “dependence”, “harm reduction” and “drug policy”.
- The research presented in the abstract is interdisciplinary and considers the management of HCV infection and/or HIV/HCV co-infection in people who inject drugs, particularly around drug dependence, harm reduction and/or drug policy issues.
Abstract submitters do not need to apply for the prize.
All abstracts that meet the criteria will be automatically considered.
Previous prize winners
See the list of winners from previous years.